Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6812
Rank
C$0.84 B
Marketcap
C$42.26
Share price
-1.03%
Change (1 day)
-6.07%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$71.49 Million

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total liabilities are C$71.49 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Avalon Pharma (Middle East Pharmaceutical) - Total liabilities on balance sheet (from 2023 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$60.64 M17.03%
2023-12-31C$51.82 M